QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A predictive model for risk of early grade >= 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial 期刊论文 2018, 卷号: 32, 期号: 6, 页码: 1404-1413 作者:  Dumontet, Charles;  Hulin, Cyrille;  Dimopoulos, Meletios A.;  Belch, Andrew;  Dispenzieri, Angela 收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03 Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma 期刊论文 2018, 卷号: 131, 期号: 3, 页码: 301-310 作者:  Facon, Thierry;  Dimopoulos, Meletios A.;  Dispenzieri, Angela;  Catalano, John V.;  Belch, Andrew 收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03 Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial 期刊论文 2015, 卷号: 126, 期号: 23 作者:  Avet-Loiseau, Herve;  Hulin, Cyrille;  Benboubker, Lofti;  Dimopoulos, Meletios A.;  Belch, Andrew 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/04 Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial 会议论文 BLOOD, 2015-12-03 作者:  Avet-Loiseau, Herve;  Hulin, Cyrille;  Benboubker, Lofti;  Dimopoulos, Meletios A.;  Belch, Andrew 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma 期刊论文 2014, 卷号: 371, 期号: 10, 页码: 906-917 作者:  Benboubker, Lotfi;  Dimopoulos, Meletios A.;  Dispenzieri, Angela;  Catalano, John;  Belch, Andrew R. 收藏  |  浏览/下载：12/0  |  提交时间：2020/01/13